| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| CHOI Man ShingExecutive Director | +1.00M | 0.72 | Bought | 394.19M | 59.72% | ||
| FU Kwok FuExecutive Director | 1.78M | -- | Derivatives expired or cancelled | 6.09M | 0.92% | ||
| KOH Ming FaiExecutive Director | 2.53M | -- | Derivatives expired or cancelled | 5.12M | 0.77% | ||
| CHOI Cheung Tai RaymondExecutive Director | 2.00M | -- | Derivatives expired or cancelled | 9.70M | 1.47% |
Changes in interests filed with HKEX by directors and chief executives. The bought/sold totals count long-position purchases and sales only; option exercises, grants and other events are left out.
| Shareholder | |||
|---|---|---|---|
| CHOI Man ShingExecutive Director | 59.72% | 394.19M | |
| CHOI Cheung Tai RaymondExecutive Director | 1.47% | 9.70M | |
| FU Kwok FuExecutive Director | 0.92% | 6.09M | |
| KOH Ming FaiExecutive Director | 0.77% | 5.12M |
From the HKEXnews Disclosure of Interests complete list of directors: each director's long position after their latest filing.
This page shows share dealings filed by VINCENT MED (01612) directors and chief executives over the past year (date, shares, price, type and holding afterwards) with bought and sold totals, and each director's current holding. Data comes from the HKEXnews Disclosure of Interests (DI) section.

